Related Experiment Video
Updated: Mar 9, 2026

Author Spotlight: In Vivo Assessment of Thyroid Hormone Disruption Using the THAI Mouse Model
Published on: October 6, 2023
Cardiac actions of thyroid hormone metabolites
Grazia Rutigliano1, Riccardo Zucchi2
1Scuola Superiore Sant'Anna, Piazza Martiri della Libertà 33, 56127 Pisa, Italy; National Research Council (CNR), Institute of Clinical Physiology (IFC), Via Giuseppe Moruzzi 1, 56124 Pisa, Italy.
Insights
Thyroid hormones (THs) and their metabolites regulate heart function through genomic and non-genomic pathways. This review details their diverse cardiac effects, including iodothyronines
Area of Science:
- Endocrinology
- Cardiovascular Physiology
- Molecular Biology
Background:
- Thyroid hormones (THs) are crucial regulators of cardiac function, primarily through genomic mechanisms.
- Emerging research highlights non-genomic actions of THs and their metabolites (THMs) in cardiac (patho)physiology.
- Understanding these diverse actions is vital for comprehending cardiac regulation.
Purpose of the Study:
- To review the classical and non-classical cardiac effects of various thyroid hormone derivatives.
- To elucidate the roles of iodothyronines, thyronamines, and iodothyroacetic acids in cardiac function.
- To synthesize current knowledge on THs' impact on cardiac performance.
Main Methods:
- Literature review of studies investigating thyroid hormone actions on the heart.
- Analysis of data concerning genomic and non-genomic effects.
- Categorization of effects based on specific thyroid hormone derivatives.
Main Results:
- Iodothyronines (T4, T3, T2) enhance cardiac systolic and diastolic function and heart rate.
- Thyronamines (T0AM, T1AM) exhibit negative inotropic and chronotropic effects, potentially acting as a brake on THs.
- Thyronamines demonstrate cardioprotective effects at physiological concentrations; cardiac roles of iodothyroacetic acids require further investigation.
Conclusions:
- Thyroid hormone derivatives exert diverse effects on cardiac function via multiple mechanisms.
- Thyronamines may play a regulatory role in cardiac function and offer cardioprotection.
- Further research is needed to fully elucidate the cardiac impact of iodothyroacetic acids.
Abstract:
Thyroid hormones (THs) have a major role in regulating cardiac function. Their classical mechanism of action is genomic. Recent findings have broadened our knowledge about the (patho)physiology of cardiac regulation by THs, to include non-genomic actions of THs and their metabolites (THM). This review provides an overview of classical and non-classical cardiac effects controlled by: i) iodothyronines (thyroxine, T4; 3,5,3'-triiodothyronine,T3; 3, 5-diiodothyronine, T2); ii) thyronamines (thyronamine, T0AM; 3-iodothyronamine, T1AM); and iii) iodothyroacetic acids (3, 5, 3', 5'-tetraiodothyroacetic acid, tetrac; 3, 5, 3'-triiodothyroacetic acid, triac; 3-iodothyroacetic acid, TA1). Whereas iodothyronines enhance both diastolic and systolic function and heart rate, thyronamines were observed to have negative inotropic and chronotropic effects and might function as a brake with respect to THs, although their physiological role is unclear. Moreover, thyronamines showed a cardioprotective effect at physiological concentrations. The cardiac effects of iodothyroacetic acids seem to be limited and need to be elucidated.
More Related Videos
Related Concept Videos
Functions of Thyroid Hormones
TH is indispensable for the normal development and maturation of the skeletal, muscular, and nervous systems during fetal and childhood growth. It facilitates bone mineral turnover and regulates protein synthesis in developing tissues, contributing significantly to overall growth and...
Synthesis and Regulation of Thyroid Hormones
Upon reaching the thyroid gland, TSH stimulates the follicular cells' active uptake of iodide ions from the blood. The ions diffuse to the apical surface of the cells and are oxidized to iodine. The...
Adrenergic Antagonists: Pharmacological Actions of β-Receptor Blockers
Heart Failure Drugs: Inotropic Agents
Antiarrhythmic Drugs: Class III Agents as Potassium Channel Blockers
Antiarrhythmic Drugs: Class II Agents as β-Adrenergic Blockers

